Imunon, Inc. (IMNN) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 12 transactions totaling $50.3K, demonstrating a bullish sentiment with $50.3K in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 8,251 shares valued at $0.
No significant insider buying has been recorded for IMNN in the recent period.
No significant insider selling has been recorded for IMNN in the recent period.
Based on recent SEC filings, insider sentiment for IMNN is bullish with an Insider Alignment Score of 100/100 and a net flow of $50.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Imunon, Inc. (IMNN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading IMNN stock, having executed 12 transactions in the past 90 days. The most active insider is James E. Dentzer (Executive), who has made 1 transactions totaling $30.5K.
Get notified when executives and directors at IMNN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Eylward Susan | General Counsel and Corp Sec | Award | 8,251 | $N/A | $0 | |
| Jan 2, 2026 | Vincent Faller Douglas | Chief Medical Officer | Award | 12,667 | $N/A | $0 | |
| Jan 2, 2026 | J. Fritz Frederick | Executive | Award | 5,892 | $N/A | $0 | |
| Jan 2, 2026 | Anwer Khursheed | Chief Scientific Officer | Award | 15,736 | $N/A | $0 | |
| Sep 6, 2025 | Lindborg Stacy | Executive | Option Exercise | 1,667 | $N/A | $0 | |
| Aug 4, 2025 | J. Fritz Frederick | Executive | Award | 3,161 | $9.20 | $29.1K | |
| Aug 4, 2025 | P. Braun Donald | Executive | Award | 2,040 | $9.20 | $18.8K | |
| Aug 4, 2025 | A. Pellizzari Christine | Executive | Award | 2,248 | $9.20 | $20.7K | |
| Aug 4, 2025 | E. Dentzer James | Executive | Award | 3,318 | $9.20 | $30.5K | |
| Aug 15, 2024 | H. Tardugno Michael | Executive | Purchase | 25,000 | $1.03 | $25.8K | |
| Aug 15, 2024 | Lindborg Stacy | Executive | Purchase | 25,000 | $0.98 | $24.5K | |
| Dec 7, 2023 | Hazard Sebastien | Executive | Award | 20,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 9 | $99.1K | 66.3% |
Purchase(P) | 2 | $50.3K | 33.7% |
Exercise(M) | 1 | $0 | 0.0% |
Insiders at Imunon, Inc. are accumulating shares at an accelerated pace. With 10 insiders making 12 transactions totaling $50.3K in purchases versus $0 in sales, the net buying activity of $50.3K signals strong executive confidence. James E. Dentzer (Executive) leads the buying activity with $30.5K in transactions across all time.